Testoxyl Propionate has the capacity to expand the nitrogen retentive properties of body tissues and assists to protein synthesis in the body tissues. The usage of steroid allows bringing more blood flow to the muscles and assists in new muscle fibers growth. Testoxyl Propionate 100 by Kalpa Pharmaceuticals is stacked with Dianabol , Winstrol and Deca-Durabolin for achievement of bulking effect, as well as with anti-estrogens Nolvadex and Proviron to avoid the negative side effects. Average Dosage: men 50-200 mg per day women – 25-50 mg. Possible side effects: irritations and swelling on the injection sites, acne, hair loss and increased body hair. The drug is very dangerous for use among women, due to its very strong virilization effects.
For the off-season athlete there is no anabolic steroid more important or beneficial than testosterone. High levels of testosterone will promote significant increases in lean muscle mass and strength. This is assuming that the individual is consuming adequate calories. Compounds like Testosterone Propionate are not magical, you will still need to feed your body enough calories. During an off-season period of growth, this means total caloric intake will need to be slightly above maintenance. This will, unfortunately, promote body fat gain. However, the key to a successful off-season is gaining lean tissue while minimizing body fat gain to the fullest extent possible. By supplementing with Testosterone Propionate you will be able to achieve this more efficiently. High testosterone levels will promote a stronger metabolic rate. This is not a license to eat like there’s no end in sight, but you should be able to make better use of your calories.
Betamethasone dipropionate was patented by Merck in 1987 as an augmented cream/lotion, Diprolene in the ., and Disprosone in Europe.  These patents expired in 2003 and 2007 respectively leading to generic production of betamethasone dipropionate. During this time other topical corticosteroids such as triamcinolone acetonide and clobetasol propionate also became available as generic creams. Merck filed for "pediatric exclusivity" in 2001 launching a clinical trial to prove betamethasone dipropionate's safety and efficacy for use in pediatrics.